Diagnosis of squamous epithelial carcinoma (SEC) comprises detecting expression of the variable exon v6 of the CD44 gene. Also new is use of antibodies (Ab) that specifically recognise an epitope in v6 for diagnosis and treatment of SEC.
申请公布号
DE19545472(A1)
申请公布日期
1997.06.12
申请号
DE1995145472
申请日期
1995.12.06
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH, 55218 INGELHEIM, DE
